Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04378101 · ClinicalTrials.gov registry record
Eating Disorders Genetics Initiative
A clinical trial of Anorexia Nervosa and Binge-Eating Disorder, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 17,991
- Enrollment target
- 3
- Study locations
NCT04378101 is a study of Anorexia Nervosa and Binge-Eating Disorder that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 17,991 participants, above the 532-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (3282% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT04378101, a study of Anorexia Nervosa and Binge-Eating Disorder, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 17,991 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overarching intention of the Eating Disorder Genetics Initiative (EDGI) is to lay the foundation for all future genomic discovery in eating disorders--anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED)--by exploring both genetic and behavioral factors. To do this, information will be collected from 4000 people who have provided DNA samples for the Anorexia Nervosa Genetics Initiative (ANGI) and the same information and DNA will be collected from an additional 16,000 people. The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed.
Conditions Studied
Interventions
- OTHER Eating disorder diagnosis group
Study Locations (3)
North Carolina
- University of North Carolina - Chapel Hill
Queensland
- QIMR Berghofer - Brisbane
Canterbury
- University of Otago - Christchurch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,991 participants |
| Start Date | 2020-06-12 |
| Est. Completion | 2023-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04378101
The ClinicalTrials.gov registry entry for NCT04378101 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17,991 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 532-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (3282% higher). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 1 intervention - of which Eating disorder diagnosis group is the first listed.
NCT04378101 reports 3 study locations spanning 3 distinct geographic areas - top geographies include North Carolina, Queensland, Canterbury.
Frequently Asked Questions
What is clinical trial NCT04378101 about?
NCT04378101 is a clinical study titled "Eating Disorders Genetics Initiative". The overarching intention of the Eating Disorder Genetics Initiative (EDGI) is to lay the foundation for all future genomic discovery in eating disorders--anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED)--by exploring both genetic and behavioral factors. To do this, infor...
What is the current status of trial NCT04378101?
This trial is currently completed. The enrollment target is 17,991 participants. The study started on 2020-06-12. Estimated completion is 2023-05-31.
What conditions does trial NCT04378101 study?
This clinical trial studies the following conditions: Anorexia Nervosa, Binge-Eating Disorder, Bulimia Nervosa.
What interventions are being tested in trial NCT04378101?
The interventions under investigation include: Eating disorder diagnosis group (OTHER).
Who is sponsoring clinical trial NCT04378101?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04378101 being conducted?
This trial has 3 study locations across North Carolina, Queensland, Canterbury. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anorexia Nervosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
RECRUITING · NA
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
RECRUITING · NA
-
Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa
RECRUITING · NA
-
Eating Disorders Genetics Initiative 2
RECRUITING
-
Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.